Novartis’ Sandoz wagers its standalone future on biosimilar success
By Natalie Grover LONDON (Reuters) – Novartis’ soon-to-be spun off generics division Sandoz is betting on biosimilars, copies of high-priced…
Business
FTX U.S. judge expresses doubts about parallel Bahamian bankruptcy
By Dietrich Knauth NEW YORK (Reuters) – The judge overseeing FTX’s U.S. bankruptcy said Thursday that he would not defer…
EU’s Breton demands Meta act against online content targeting children
By Foo Yun Chee BRUSSELS (Reuters) -EU industry chief Thierry Breton will meet Meta Platforms Chief Executive Mark Zuckerberg on…
Chinese regulators try to assure sceptical foreign financiers
By Jason Xue and Joe Cash SHANGHAI/BEIJING (Reuters) – China is open for investment, the country’s top financial regulators told…
Crypto companies made ‘calculated’ decision to flout rules, says SEC chair
By John McCrank and Hannah Lang (Reuters) -The chair of the U.S. Securities and Exchange Commission (SEC) on Thursday strongly…
Carvana shares surge as much as 68% after upbeat second-quarter outlook
By Nathan Gomes and Sinéad Carew (Reuters) -Shares of used-car retailer Carvana Co closed up 56.0% on Thursday with some…
GM to invest more than $500 million in Texas plant for future SUVs
By David Shepardson (Reuters) -General Motors said Thursday it will invest more than $500 million in its Arlington, Texas assembly…
Shares rise, Treasury yields fall as US jobless claims surge
By Marc Jones and Koh Gui Qing NEW YORK/LONDON (Reuters) – World stocks rose on Thursday and Treasury yields edged…
Oil prices partially recover after US, Iran deny reported nuclear deal
By Laura Sanicola (Reuters) -Oil prices settled lower on Thursday but rebounded from earlier losses after the U.S. and Iran…
Behold Wall Street’s new bull market, maybe
By Chuck Mikolajczak NEW YORK (Reuters) -S&P 500 advanced on Thursday, putting the benchmark index up 20% from its Oct….